Insulin-enhancing activity of a dinuclear vanadium complex: 5-chloro-salicylaldhyde ethylenediamine oxovanadium(V) and its permeability and cytotoxicity

A new insulin-enhancing oxovanadium complex 5-chloro-salicylaldhyde ethylenediamine oxovanadium (V) ([V(2)O(2)(mu-O)(2)L(2)]) has been synthesized. The complex was characterized by a variety of physical methods, including X-ray crystallography. The X-ray diffraction analysis show a dinuclear complex of two six-coordinate vanadium centers doubly bridged by the oxygen atoms of the Schiff base ligand with a V(2)O(2) diamond core. The complex was administered intragastrically to STZ-diabetic rats for 2 weeks. The biological activity results show that the complex at the dose of 10.0 and 20.0 mg V kg(-1), could significantly decrease the blood glucose level and ameliorate impaired glucose tolerance in STZ-diabetic rats. That results suggested that the complex exerts an antidiabetic effect in STZ-diabetic rats. Furthermore, the complex ([V(2)O(2)(mu-O)(2)L(2)]) had permeability above 10(-5)cm/s. The experimental results suggested that the vanadium complex permeates via a passive diffusion mechanism. It was also suggested the complex with salen-type ligands has good lipophilic properties and better oral administration. The cytotoxicity of the complex ([V(2)O(2)(mu-O)(2)L(2)]) on Caco-2 cells was measured by a decrease of cell viability using the MTT assay suggesting that the chlorine atom at C4 of complex [V(2)O(2)(mu-O)(2)L(2)] increased cytotoxicity for vanadium complexes.

Synthesis, characterisation, reactivity and in vitro antiamoebic activity of hydrazone based oxovanadium(iv), oxovanadium(v) and µ-bis(oxo)bis{oxovanadium(v)} complexes

Binuclear, mu-bis(oxo)bis{oxovanadium(V)} complexes [(VOL)2(mu-O)2](2 and 7)(where HL are the hydrazones Hacpy-nah I or Hacpy-fah II; acpy = 2-acetylpyridine, nah = nicotinic acid hydrazide and fah = 2-furoic acid hydrazide) were prepared by the reaction of [VO(acac)2] and the ligands in methanol followed by aerial oxidation. The paramagnetic intermediate complexes [VO(acac)(acpy-nah)](1) and [VO(acac)(acpy-fah)](6) have also been isolated. Treatment of [VO(acac)(acpy-nah)] and [VO(acac)(acpy-fah)] with aqueous H2O2 yields the oxoperoxovanadium(V) complexes [VO(O2)(acpy-nah)](3) and [VO(O2)(acpy-fah)](8). In the presence of catechol (H2cat) or benzohydroxamic acid (H2bha), 1 and 6 give the mixed chelate complexes [VO(cat)L](HL =I: 4, HL =II: 9) or [VO(bha)L](HL =I: 5, HL =II: 10). Complexes 4, 5, 9 and 10 slowly convert to the corresponding oxo-mu-oxo species 2 and 7 in DMF solution. Ascorbic acid enhances this conversion under aerobic conditions, possibly through reduction of these complexes with concomitant removal of coordinated catecholate or benzohydroxamate. Acidification of 7 with HCl dissolved in methanol afforded a hydroxo(oxo) complex. The crystal and molecular structure of 2.1.5H2O has been determined, and the structure of 7 re-determined, by single crystal X-ray diffraction. Both of these binuclear complexes contain the uncommon asymmetrical {VO(mu-O)}2 diamond core. The in vitro tests of the antiamoebic activity of ligands I and II and their binuclear complexes 2 and 7 against the protozoan parasite Entamoeba histolytica show that the ligands have no amoebicidal activity while their vanadium complexes 2 and 7 display more effective amoebicidal activity than the most commonly used drug metronidazole (IC50 values are 1.68 and 0.45 microM, respectively vs 1.81 microM for metronidazole). Complexes 2 and 7 catalyse the oxidation of styrene and ethyl benzene effectively. Oxidation of styrene, using H2O2 as an oxidant, gives styrene epoxide, 2-phenylacetaldehyde, benzaldehyde, benzoic acid and 1-phenyl-ethane-1,2-diol, while ethyl benzene yields benzyl alcohol, benzaldehyde and 1-phenyl-ethane-1,2-diol.

Molecular and supramolecular features of oxo-peroxovanadium complexes containing O3N, O2N2and ON3donor sets

The complexes [VO(O2)Hbpa]+ (1a), [VO(O2)bpa] (1b, Hbpa = bis(picolyl)-beta-alanine), [VO(O2)heida]- (2, H2heida =N-(2-hydroxyethyl)iminodiacetic acid), [VO(O2)(3OH-pic)2]- (3a), [VO(O2)(3OH-pic)2]-/[V(O2)2(3OH-pic)2]- (3b, 3OH-pic = 3-hydroxypicolinic acid), [VO(O2)(3OH-pa)2] (6, 3OH-pa = 3-hydroxypicolylamide), [VO2(3OH-pic)2]- (4), [VO(tBuO2)(3OH-pic)2] (5) and [VO(tBuO2)(3OH-pa)2]2+ (7) have been characterised. The structures of 21a[ClO4].1b.2.25H2O, K.2H2O, [NH4].H2O and [nBu4]3b are reported. Supramolecular patterns arise from intermolecular hydrogen bonds, the relevance of which for the peroxo/hydroperoxo intermediates in oxo transfer reactions catalysed by vanadate-dependent haloperoxidases is addressed. Specific solution patterns have been analysed by 51V and 17O NMR.

Molecular, supramolecular and solution structures of peroxovanadium complexes with ON and O3N donor set ligands: two new types of cationic–anionic peroxovanadium(v) peroxovanadates(v)

The complexes, [VO(O(2))(pa)(2)]ClO(4).3H(2)O (1), [VO(O(2))(pa)(2)][VO(O(2))(2)(pa)].3H(2)O (2), [VO(O(2))(pa)(2)][VO(O(2))(ada)].2H(2)O (3) and [VO(O(2))(pa)(pca)].H(2)O (4)[pa = picolinamide, ada = carbamoylmethyliminodiacetate(2-) and pca = 2-pyrazinecarboxylate(1-)], were synthesized. 2 and 3 are new types of peroxovanadium complexes: monoperoxovanadium diperoxovanadate (2) and monoperoxovanadium monoperoxovanadate (3). The complexes were characterized by chemical analysis and IR spectroscopy, and 1, 3 and 4 also by X-ray analysis. The structure of 1 is disordered, with alternating positions of the oxo and peroxo ligands. The peroxo oxygen atoms, O(p), in 1 are involved in weak hydrogen bonds with water molecules and close intramolecular C-HO...(p) bonds [d(HO(p)) approximately 2.0 A]. The supramolecular structure of 1 is formed by a network of hydrogen bonds and strong attractive intermolecular pi-pi interactions between the pyridine rings. The supramolecular architecture in 4 is constructed by (N,O)-H...O hydrogen bonds between the neutral complex molecules and water of crystallization. The peroxo oxygen atoms in 4 form intramolecular C-H...O(p) bonds [d(H...O(p))= 2.303 A]. The pa and pca ligands are ON coordinated via the oxygen atoms of the C(NH(2))=O and COO(-) groups, respectively, and nitrogen atoms of the heterocyclic rings, and ada as a tetradentate O(3)N ligand. The thermal analysis of 4 showed that the loss of water of crystallization and the active oxygen release (T(min)/ degrees C 82, T(max)/degrees C 165) are, under given conditions, individual processes separated by the temperature interval 90-132 degrees C. The solution structures and stability were studied by UV-VIS and (51)V NMR spectroscopies.